Novo Nordisk Will Use Anthropic’s Claude and Claude Science for Drug Research in a New AI Pharmaceutical R&D Partnership
Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, announced a new collaboration with Anthropic on September 16 that will bring Claude’s frontier AI models, including the specialized Claude Science platform, directly into the company’s drug discovery and development workflows. The deal marks the latest in a string of technology partnerships Novo has struck … Read more